Skip to main content

MILLENNIUM MANAGEMENT LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1273087 NEW YORK, NY

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,734,132
+$2,118,518 QoQ
Shares Held
356,471
+554.9% QoQ
Ownership
0.535%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 168 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Derivatives in FULC

reported options exposure · as of Mar 31, 2022
CallValue
$827,750
CallShares
35,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $4,466,124,984 across 340 Biotechnology names. FULC ranks #224 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FULC

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,734,132 356,471
2025-12-31 $615,614 54,431
2025-09-30 $1,387,976 150,867
2025-06-30 $727,167 105,693
2025-03-31 $117,192 40,692
2024-12-31 $357,778 76,123
2024-09-30 $83,877 23,495
2024-06-30 $2,497,043 402,749
2024-03-31 $8,472,031 897,461
2023-12-31 $2,953,145 437,503
2023-09-30 $4,460,788 1,004,682
2023-06-30 $1,897,028 574,857
2023-03-31 $1,768,593 620,559
2022-06-30 $397,865 81,197
2022-03-31 $827,750 35,000
2021-12-31 $284,809 16,100
2021-12-31 $1,032,653 58,375
2021-09-30 $2,812,734 99,707
2021-06-30 $6,556,654 625,635
2021-03-31 $7,009,818 595,061
2020-12-31 $455,074 38,862
2020-06-30 $858,660 46,947
2020-03-31 $2,209,126 185,019